UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Engineered mitochondrial ROS scavenger nanocomplex to enhance lung biodistribution and reduce inflammation for the treatment of ARDS

Advanced composites and hybrid materials, 2024-12, Vol.7 (6), Article 194

2024

Volltextzugriff (PDF)

Wunderlich syndrome in pregnancy: life threatening bleeding renal angiomyolipoma in first and third trimesters—two case reports and literature review

African journal of urology, 2024-12, Vol.30 (1), p.55-5, Article 55

2024

Volltextzugriff (PDF)

Deciphering heart failure: an integrated proteomic and transcriptomic approach with experimental validation

Functional & integrative genomics, 2024-12, Vol.24 (6), p.196, Article 196

2024

Volltextzugriff (PDF)

Dual metal–organic-frameworks mediated resonance energy transfer for ultrasensitive electrochemiluminescence immunosensing

Mikrochimica acta (1966), 2024-11, Vol.191 (11), p.707, Article 707

2024

Volltextzugriff (PDF)

Abstracts of the 18th International Congress on Neuromuscular Diseases (ICNMD 2024)

Journal of neuromuscular diseases, 2024-11, Vol.11 (2_suppl), p.S1-S187

2024

Volltextzugriff (PDF)

Molecular mechanisms and clinicopathological characteristics of inhibin [beta]A in thyroid cancer metastasis

International journal of molecular medicine, 2024-11, Vol.54 (5), p.1

2024

Volltextzugriff (PDF)

Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer

Cell discovery, 2024-10, Vol.10 (1), p.109, Article 109

2024

Volltextzugriff (PDF)

RACK1 contributes to the upregulation of embryonic genes in a model of cardiac hypertrophy

Scientific reports, 2024-10, Vol.14 (1), p.25698, Article 25698

2024

Volltextzugriff (PDF)

Characteristic disease defects in circulating endothelial cells isolated from patients with pulmonary arterial hypertension

PloS one, 2024-10, Vol.19 (10), p.e0312535

2024

Volltextzugriff (PDF)

ZSTK474 targeting PIK3R3 inhibits the Wilms’ tumor through G0 / G1 phase arrest

PloS one, 2024-10, Vol.19 (10), p.e0312178

2024

Volltextzugriff (PDF)

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Business Wire, 2024-10-28

2024

Volltextzugriff (PDF)

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Business Wire, 2024

2024

Volltextzugriff (PDF)

Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets

Journal of molecular neuroscience, 2024-10, Vol.74 (4), p.101, Article 101

2024

Volltextzugriff (PDF)

Multiple cell types including melanocytes contribute to elastogenesis in the developing murine aortic valve

Scientific reports, 2024-10, Vol.14 (1), p.25481-12, Article 25481

2024

Volltextzugriff (PDF)

The mechanism of NF-[kappa]B-TERT feedback regulation of granulosa cell apoptosis in PCOS rats

PloS one, 2024-10, Vol.19 (10), p.e0312115

2024

Volltextzugriff (PDF)

Stimulation of insulin secretion induced by low 4-cresol dose involves the RPS6KA3 signalling pathway

PloS one, 2024-10, Vol.19 (10), p.e0310370

2024

Volltextzugriff (PDF)

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers

Business Wire, 2024

2024

Volltextzugriff (PDF)

Merck's KEYTRUDA (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers

Business Wire, 2024-10-24

2024

Volltextzugriff (PDF)

Synergistic effect of venetoclax and teglicar in multiple myeloma cell lines

Farmacija, 2024-10, Vol.71 (3), p.1-9

2024

Volltextzugriff (PDF)

Propionibacterium freudenreichii MJ2-derived extracellular vesicles inhibit RANKL-induced osteoclastogenesis and improve collagen-induced rheumatoid arthritis

Scientific reports, 2024-10, Vol.14 (1), p.24973-15, Article 24973

2024

Volltextzugriff (PDF)

Preliminary proteomic analysis of mouse lung tissue treated with cyclophosphamide and Venetin-1

Scientific reports, 2024-10, Vol.14 (1), p.25056-17, Article 25056

2024

Volltextzugriff (PDF)

The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo

Stem cell research & therapy, 2024-10, Vol.15 (1), p.375-27, Article 375

2024

Volltextzugriff (PDF)

Short- and long-term outcomes of laparoscopic right hemicolectomy with D3 resection for right colon cancer in elderly patients

Langenbeck's archives of surgery, 2024-10, Vol.409 (1), p.320, Article 320

2024

Volltextzugriff (PDF)

Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma

PloS one, 2024-10, Vol.19 (10), p.e0300411

2024

Volltextzugriff (PDF)

Epicardial transplantation of antioxidant polyurethane scaffold based human amniotic epithelial stem cell patch for myocardial infarction treatment

Nature communications, 2024-10, Vol.15 (1), p.9105-16, Article 9105

2024

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 30 Tagen

ThemaFemale

ThemaGenetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Englisch
(164)
Portugiesisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Engineered mitochondrial ROS scavenger nanocomplex to enhance lung biodistribution and reduce inflammation for the treatment of ARDS

Wunderlich syndrome in pregnancy: life threatening bleeding renal angiomyolipoma in first and third trimesters—two case reports and literature review

Deciphering heart failure: an integrated proteomic and transcriptomic approach with experimental validation

Dual metal–organic-frameworks mediated resonance energy transfer for ultrasensitive electrochemiluminescence immunosensing

Abstracts of the 18th International Congress on Neuromuscular Diseases (ICNMD 2024)

Molecular mechanisms and clinicopathological characteristics of inhibin [beta]A in thyroid cancer metastasis

Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer

RACK1 contributes to the upregulation of embryonic genes in a model of cardiac hypertrophy

Characteristic disease defects in circulating endothelial cells isolated from patients with pulmonary arterial hypertension

ZSTK474 targeting PIK3R3 inhibits the Wilms’ tumor through G0 / G1 phase arrest

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets

Multiple cell types including melanocytes contribute to elastogenesis in the developing murine aortic valve

The mechanism of NF-[kappa]B-TERT feedback regulation of granulosa cell apoptosis in PCOS rats

Stimulation of insulin secretion induced by low 4-cresol dose involves the RPS6KA3 signalling pathway

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers

Merck's KEYTRUDA (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers

Synergistic effect of venetoclax and teglicar in multiple myeloma cell lines

Propionibacterium freudenreichii MJ2-derived extracellular vesicles inhibit RANKL-induced osteoclastogenesis and improve collagen-induced rheumatoid arthritis

Preliminary proteomic analysis of mouse lung tissue treated with cyclophosphamide and Venetin-1

The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo

Short- and long-term outcomes of laparoscopic right hemicolectomy with D3 resection for right colon cancer in elderly patients

Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma

Epicardial transplantation of antioxidant polyurethane scaffold based human amniotic epithelial stem cell patch for myocardial infarction treatment

Aktive Filter

Suchergebnisse filtern